Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5486507 | 0.79 | HTR2A (0.44) | TAAR1POLBRAB9AALDH1A1 | |
| SCHEMBL9493113 | 0.79 | MAPT (0.41) | POLBHPGDCYP3A4ALDH1A1 | |
| SCHEMBL6441730 | 0.79 | POLB (0.47) | TAAR1POLBTRPA1AOC3FFAR1 | |
| SCHEMBL5929946 | 0.79 | TSHR (0.57) | POLBFFAR1HPGDCYP3A4CYP2C19 | |
| SCHEMBL6731462 | 0.78 | POLB (0.46) | TAAR1POLBTRPA1AOC3FFAR1 | |
| SCHEMBL8835511 | 0.77 | TAAR1 (0.54) | TAAR1POLBTRPA1AOC3FFAR1 | |
| SCHEMBL27473927 | 0.77 | TAAR1 (0.54) | TAAR1POLBTRPA1AOC3FFAR1 | |
| SCHEMBL7398650 | 0.76 | ACHE (0.60) | TAAR1POLBTRPA1FFAR1HPGD | |
| SCHEMBL237090 | 0.76 | FFAR1 (0.70) | TAAR1POLBTRPA1FFAR1HPGD | |
| SCHEMBL19381474 | 0.76 | TAAR1 (0.52) | TAAR1POLBTRPA1AOC3FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2589643-B1 | HIGHLY EFFICIENT CARBAZOLE-BASED COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | SK CHEMICALS CO LTD (KR) | 2017-09-20 | — | — | EP | disclosed |
| US-9142784-B2 | Highly efficient carbazole-based compound, and organic electroluminescence device comprising same | SK CHEMICALS CO., LTD. (KR) | 2015-09-22 | — | — | US | disclosed |
| CN-102959040-B | High-efficiency carbazole-based compound and organic electroluminescent device comprising same | SK CHEMICALS CO LTD | 2015-05-20 | — | — | CN | disclosed |
| US-20130119367-A1 | HIGHLY EFFICIENT CARBAZOLE-BASED COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | INDUSTRY ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) | 2013-05-16 | — | — | US | disclosed |
| EP-2589643-A2 | HIGHLY EFFICIENT CARBAZOLE-BASED COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | Industry-Academic Cooperation Foundation, Dankook University (KR) | 2013-05-08 | — | — | EP | disclosed |
| CN-102959040-A | High-efficiency carbazole-based compound and organic electroluminescent device comprising same | UNIV DANKOOK IACF | 2013-03-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130119367-A1 | HIGHLY EFFICIENT CARBAZOLE-BASED COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | PPIP5K2, INPP5B, EZH2 | TAAR1 4528/4885POLB 2100/4885TRPA1 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.